<VariationArchive VariationID="2001811" VariationName="NM_006265.3(RAD21):c.1045dup (p.Thr349fs)" VariationType="Duplication" Accession="VCV002001811" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2055012" VariationID="2001811">
      <GeneList>
        <Gene Symbol="RAD21" FullName="RAD21 cohesin complex component" GeneID="5885" HGNC_ID="HGNC:9811" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q24.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="116845934" stop="116874776" display_start="116845934" display_stop="116874776" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="117858172" stop="117887104" display_start="117858172" display_stop="117887104" Strand="-" />
          </Location>
          <OMIM>606462</OMIM>
          <Haploinsufficiency last_evaluated="2022-03-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAD21">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-03-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAD21">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006265.3(RAD21):c.1045dup (p.Thr349fs)</Name>
      <CanonicalSPDI>NC_000008.11:116854360:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q24.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="116854360" stop="116854361" display_start="116854360" display_stop="116854361" variantLength="1" positionVCF="116854360" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="117866599" stop="117866600" display_start="117866599" display_stop="117866600" variantLength="1" positionVCF="117866599" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>T349fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.117866600dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.117866600dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.116854361dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.116854361dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032862.1" sequenceAccession="NG_032862" sequenceVersion="1" change="g.25506dup">
            <Expression>NG_032862.1:g.25506dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006265.3" sequenceAccession="NM_006265" sequenceVersion="3" change="c.1045dup" MANESelect="true">
            <Expression>NM_006265.3:c.1045dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006256.1" sequenceAccession="NP_006256" sequenceVersion="1" change="p.Thr349fs">
            <Expression>NP_006256.1:p.Thr349fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_772" sequenceAccession="LRG_772">
            <Expression>LRG_772:g.25506dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_772t1" sequenceAccession="LRG_772t1">
            <Expression>LRG_772t1:c.1045dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_772p1" sequenceAccession="LRG_772p1" change="p.Thr349Asnfs">
            <Expression>LRG_772p1:p.Thr349Asnfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006265.3(RAD21):c.1045dup (p.Thr349fs) AND Cornelia de Lange syndrome 4" Accession="RCV002832839" Version="2">
        <ClassifiedConditionList TraitSetID="8701">
          <ClassifiedCondition DB="MedGen" ID="C3553517">Cornelia de Lange syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22633399</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24378232</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27620904</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27882533</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8701" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17306" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cornelia de Lange syndrome 4</ElementValue>
                <XRef ID="MONDO:0013864" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CORNELIA DE LANGE SYNDROME 4 WITH OR WITHOUT MIDLINE BRAIN DEFECTS</ElementValue>
                <XRef Type="MIM" ID="614701" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CDLS4</ElementValue>
                <XRef Type="MIM" ID="614701" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15837" />
                <XRef ID="15837" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features, growth restriction (prenatal onset; &lt;5th centile throughout life), hypertrichosis, and upper-limb reduction defects that range from subtle phalangeal abnormalities to oligodactyly (missing digits). Craniofacial features include synophrys, highly arched and/or thick eyebrows, long eyelashes, short nasal bridge with anteverted nares, small widely spaced teeth, and microcephaly. Individuals with a milder phenotype have less severe growth, cognitive, and limb involvement, but often have facial features consistent with CdLS. Across the CdLS spectrum IQ ranges from below 30 to 102 (mean: 53). Many individuals demonstrate autistic and self-destructive tendencies. Other frequent findings include cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia.</Attribute>
                <XRef ID="NBK1104" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301283</ID>
                <ID Source="BookShelf">NBK1104</ID>
              </Citation>
              <XRef ID="199" DB="Orphanet" />
              <XRef ID="C3553517" DB="MedGen" />
              <XRef ID="MONDO:0013864" DB="MONDO" />
              <XRef Type="MIM" ID="614701" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5894857" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16788850|MedGen:C3553517" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003209707" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22633399</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24378232</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27620904</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27882533</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with RAD21-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr349Asnfs*35) in the RAD21 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAD21 are known to be pathogenic (PMID: 22633399, 24378232, 27620904, 27882533).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAD21" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.117866599_117866600insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553517" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5894857" TraitType="Disease" MappingType="XRef" MappingValue="C3553517" MappingRef="MedGen">
        <MedGen CUI="C3553517" Name="Cornelia de Lange syndrome 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

